| parvovirus b19 and autoimmune diseases. | parvovirus b19 (b19) causes many clinical disorders, of which the most common are erythema infectiosum, aplastic crisis complicating chronic hemolytic anemia, and hydrops fetalis. in young adults, the skin eruption caused by b19 is accompanied with polyarthritis and polyarthralgia in 60% of the cases. the joint abnormalities predominate in the hands and feet and usually resolve within a week (range 2-21 d). serological tests show igm antibodies against b19, confirming the diagnosis of recent inf ... | 2003 | 12639611 |
| [systemic manifestations of parvovirus b19 infections]. | purpose: parvovirus b19 (b19) causes many clinical disorders, of which the most common are erythema infectiosum, aplastic crisis complicating chronic hemolytic anemia, and hydrops fetalis. in young adults, the skin eruption caused by b19 is accompanied by polyarthritis and polyarthralgia in 60% of the cases. rheumatoid factors and other antibodies including antinuclear antibodies, anti-adn, and antiphospholipids can be produced in the wake of b19 infection. current knowledge and key points: thes ... | 2004 | 15471600 |
| emerging infectious diseases that threaten the blood supply. | following the devastating effects of blood-transmitted human immunodeficiency virus (hiv), blood establishments have become increasingly vigilant for the emergence or re-emergence of new threats to the safety of the blood supply. many agents have fulfilled the broad definition of emerging blood-transmitted infections, including west nile virus (wnv), trypanosoma cruzi, plasmodium spp., babesia spp., parvovirus b19, dengue virus, and the prions that cause variant creutzfeld-jacob disease (vcjd). ... | 2007 | 17198845 |